Bio-Path Holdings
Why Robinhood?
You can watch BPTH and buy or sell other stocks, ETFs, and their options commission-free!About BPTH
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1002, and BP1003.
BPTH Key Statistics
Stock Snapshot
Bio-Path Holdings(BPTH) stock is priced at $3.78, giving the company a market capitalization of 46.99M. It carries a P/E multiple of -3.50.
On 2026-05-03, Bio-Path Holdings(BPTH) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Bio-Path Holdings(BPTH) stock has reached 0, versus its average volume of 203.55K.
The stock's 52-week range extends from a low of $0.32 to a high of $2.24.
The stock's 52-week range extends from a low of $0.32 to a high of $2.24.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.